Announcement • Jun 03
Dr.Finance S.A., Annual General Meeting, Jun 26, 2026 Dr.Finance S.A., Annual General Meeting, Jun 26, 2026, at 10:00 Central European Standard Time. Announcement • May 27
Dr.Finance S.A. to Report Fiscal Year 2025 Results on May 26, 2026 Dr.Finance S.A. announced that they will report fiscal year 2025 results on May 26, 2026 New Risk • May 25
New major risk - Revenue size The company makes less than US$1m in revenue. Total revenue: zł2.4m (US$667k) This is considered a major risk. Companies with a small amount of revenue are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (16% average weekly change). Earnings have declined by 34% per year over the past 5 years. Revenue is less than US$1m (zł2.4m revenue, or US$667k). Market cap is less than US$10m (zł6.81m market cap, or US$1.87m). New Risk • May 23
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Polish stocks, typically moving 11% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (11% average weekly change). Earnings have declined by 40% per year over the past 5 years. Market cap is less than US$10m (zł4.94m market cap, or US$1.35m). Minor Risks Latest financial reports are more than 6 months old (reported September 2025 fiscal period end). Revenue is less than US$5m (zł9.4m revenue, or US$2.6m). New Risk • May 07
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 40% per year over the past 5 years. Market cap is less than US$10m (zł4.53m market cap, or US$1.26m). Minor Risks Latest financial reports are more than 6 months old (reported September 2025 fiscal period end). Share price has been volatile over the past 3 months (9.4% average weekly change). Revenue is less than US$5m (zł9.4m revenue, or US$2.6m). Reported Earnings • Oct 22
Third quarter 2025 earnings released Third quarter 2025 results: Revenue: zł2.39m (down 7.2% from 3Q 2024). Net loss: zł106.8k (loss widened 2.8% from 3Q 2024). Reported Earnings • Aug 19
Second quarter 2025 earnings released Second quarter 2025 results: Revenue: zł2.40m (up 4.9% from 2Q 2024). Net income: zł130.2k (up zł274.4k from 2Q 2024). Profit margin: 5.4% (up from net loss in 2Q 2024). Over the last 3 years on average, earnings per share has fallen by 31% per year but the company’s share price has only fallen by 11% per year, which means it has not declined as severely as earnings. Reported Earnings • May 17
First quarter 2025 earnings released First quarter 2025 results: Revenue: zł2.12m (down 28% from 1Q 2024). Net loss: zł108.8k (loss widened 91% from 1Q 2024). Reported Earnings • Aug 18
Second quarter 2024 earnings released Second quarter 2024 results: Revenue: zł2.29m (up 88% from 2Q 2023). Net loss: zł144.2k (loss widened 248% from 2Q 2023). Announcement • Jun 05
Dr.Finance S.A., Annual General Meeting, Jun 28, 2024 Dr.Finance S.A., Annual General Meeting, Jun 28, 2024. Reported Earnings • May 19
First quarter 2024 earnings released First quarter 2024 results: Revenue: zł2.95m (up 296% from 1Q 2023). Net loss: zł57.0k (loss widened 400% from 1Q 2023). Reported Earnings • Feb 11
Full year 2023 earnings released: zł0.002 loss per share (vs zł0.053 loss in FY 2022) Full year 2023 results: zł0.002 loss per share (improved from zł0.053 loss in FY 2022). Revenue: zł6.22m (down 17% from FY 2022). Net loss: zł7.7k (loss narrowed 96% from FY 2022). Over the last 3 years on average, earnings per share has fallen by 52% per year but the company’s share price has only fallen by 23% per year, which means it has not declined as severely as earnings. Reported Earnings • Nov 19
Third quarter 2023 earnings released Third quarter 2023 results: Revenue: zł1.51m (down 1.2% from 3Q 2022). Net income: zł28.1k (up zł33.5k from 3Q 2022). Profit margin: 1.9% (up from net loss in 3Q 2022). The move to profitability was driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 57 percentage points per year, which is a significant difference in performance. Reported Earnings • Aug 18
Second quarter 2023 earnings released Second quarter 2023 results: Revenue: zł1.21m (down 43% from 2Q 2022). Net loss: zł41.4k (loss narrowed 47% from 2Q 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 107 percentage points per year, which is a significant difference in performance. Announcement • Jun 13
Dr.Finance S.A., Annual General Meeting, Jun 29, 2023 Dr.Finance S.A., Annual General Meeting, Jun 29, 2023, at 12:00 Central European Standard Time. Announcement • Nov 15
Dr.Finance S.A. to Report Q3, 2022 Results on Nov 15, 2022 Dr.Finance S.A. announced that they will report Q3, 2022 results on Nov 15, 2022 Valuation Update With 7 Day Price Move • Jun 29
Investor sentiment improved over the past week After last week's 16% share price gain to zł1.04, the stock trades at a trailing P/E ratio of 33x. Average trailing P/E is 18x in the Capital Markets industry in Poland. Total returns to shareholders of 234% over the past three years. Announcement • Jun 02
Dr.Finance S.A., Annual General Meeting, Jun 27, 2022 Dr.Finance S.A., Annual General Meeting, Jun 27, 2022, at 10:00 Central European Standard Time. Reported Earnings • Apr 27
First quarter 2022 earnings released First quarter 2022 results: Revenue: zł2.97m (up 54% from 1Q 2021). Net loss: zł72.1k (loss widened 107% from 1Q 2021). Valuation Update With 7 Day Price Move • Mar 04
Investor sentiment improved over the past week After last week's 16% share price gain to zł1.09, the stock trades at a trailing P/E ratio of 26.4x. Average trailing P/E is 14x in the Capital Markets industry in Poland. Total returns to shareholders of 173% over the past three years. Reported Earnings • Feb 18
Full year 2021 earnings: Revenues and EPS in line with analyst expectations Full year 2021 results: EPS: zł0.041 (up from zł0.004 loss in FY 2020). Revenue: zł11.7m (up 52% from FY 2020). Net income: zł154.5k (up zł168.0k from FY 2020). Profit margin: 1.3% (up from net loss in FY 2020). The move to profitability was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 103 percentage points per year, which is a significant difference in performance. Valuation Update With 7 Day Price Move • Jan 19
Investor sentiment deteriorated over the past week After last week's 21% share price decline to zł1.07, the stock trades at a trailing P/E ratio of 28.3x. Average trailing P/E is 15x in the Capital Markets industry in Poland. Total returns to shareholders of 161% over the past three years. Valuation Update With 7 Day Price Move • Jan 03
Investor sentiment improved over the past week After last week's 18% share price gain to zł1.30, the stock trades at a trailing P/E ratio of 34.3x. Average trailing P/E is 16x in the Capital Markets industry in Poland. Total returns to shareholders of 182% over the past three years. Valuation Update With 7 Day Price Move • Nov 22
Investor sentiment improved over the past week After last week's 21% share price gain to zł1.39, the stock trades at a trailing P/E ratio of 36.8x. Average trailing P/E is 15x in the Capital Markets industry in Poland. Total returns to shareholders of 202% over the past three years. Valuation Update With 7 Day Price Move • Oct 28
Investor sentiment deteriorated over the past week After last week's 19% share price decline to zł1.24, the stock trades at a trailing P/E ratio of 32.7x. Average trailing P/E is 14x in the Capital Markets industry in Poland. Total returns to shareholders of 187% over the past three years. Reported Earnings • Oct 19
Third quarter 2021 earnings released The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: zł3.49m (up 79% from 3Q 2020). Net income: zł191.4k (up 460% from 3Q 2020). Profit margin: 5.5% (up from 1.8% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 151 percentage points per year, which is a significant difference in performance. Reported Earnings • Apr 17
First quarter 2021 earnings released The company reported a soft first quarter result with increased losses and weaker control over costs, although revenues improved. First quarter 2021 results: Revenue: zł1.93m (up 12% from 1Q 2020). Net loss: zł34.9k (loss widened 166% from 1Q 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 124 percentage points per year, which is a significant difference in performance. Reported Earnings • Feb 17
Full year 2020 earnings released: EPS zł0.012 (vs zł0.05 in FY 2019) The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2020 results: Revenue: zł7.72m (up 7.5% from FY 2019). Net income: zł43.2k (down 77% from FY 2019). Profit margin: 0.6% (down from 2.6% in FY 2019). Over the last 3 years on average, earnings per share has fallen by 59% per year but the company’s share price has increased by 51% per year, which means it is well ahead of earnings. Valuation Update With 7 Day Price Move • Feb 15
Investor sentiment improved over the past week After last week's 15% share price gain to zł1.37, the stock is trading at a trailing P/E ratio of 60.4x, up from the previous P/E ratio of 52.5x. This compares to an average P/E of 13x in the Capital Markets industry in Poland. Total returns to shareholders over the past three years are 270%. Valuation Update With 7 Day Price Move • Jan 15
Investor sentiment deteriorated over the past week After last week's 17% share price decline to zł1.33, the stock is trading at a trailing P/E ratio of 58.7x, down from the previous P/E ratio of 70.6x. This compares to an average P/E of 11x in the Capital Markets industry in Poland. Total returns to shareholders over the past three years are 217%. Is New 90 Day High Low • Dec 28
New 90-day high: zł1.73 The company is up 281% from its price of zł0.45 on 29 September 2020. The Polish market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Capital Markets industry, which is up 4.0% over the same period. Valuation Update With 7 Day Price Move • Dec 28
Investor sentiment improved over the past week After last week's 15% share price gain to zł1.73, the stock is trading at a trailing P/E ratio of 76.3x, up from the previous P/E ratio of 66.2x. This compares to an average P/E of 9x in the Capital Markets industry in Poland. Total returns to shareholders over the past three years are 220%. Valuation Update With 7 Day Price Move • Dec 23
Investor sentiment improved over the past week After last week's 18% share price gain to zł1.49, the stock is trading at a trailing P/E ratio of 65.7x, up from the previous P/E ratio of 55.6x. This compares to an average P/E of 9x in the Capital Markets industry in Poland. Total returns to shareholders over the past three years are 239%. Valuation Update With 7 Day Price Move • Dec 21
Investor sentiment improved over the past week After last week's 22% share price gain to zł1.50, the stock is trading at a trailing P/E ratio of 66.2x, up from the previous P/E ratio of 54.2x. This compares to an average P/E of 9x in the Capital Markets industry in Poland. Total returns to shareholders over the past three years are 200%. Valuation Update With 7 Day Price Move • Dec 07
Market bids up stock over the past week After last week's 16% share price gain to zł1.28, the stock is trading at a trailing P/E ratio of 56.5x, up from the previous P/E ratio of 48.5x. This compares to an average P/E of 9x in the Capital Markets industry in Poland. Total returns to shareholders over the past three years are 156%. Valuation Update With 7 Day Price Move • Nov 19
Market pulls back on stock over the past week After last week's 15% share price decline to zł1.05, the stock is trading at a trailing P/E ratio of 46.3x, down from the previous P/E ratio of 54.7x. This compares to an average P/E of 11x in the Capital Markets industry in Poland. Total returns to shareholders over the past three years are 102%. Valuation Update With 7 Day Price Move • Nov 10
Market bids up stock over the past week After last week's 24% share price gain to zł1.23, the stock is trading at a trailing P/E ratio of 54.2x, up from the previous P/E ratio of 43.7x. This compares to an average P/E of 11x in the Capital Markets industry in Poland. Total returns to shareholders over the past three years are 128%. Valuation Update With 7 Day Price Move • Nov 05
Market bids up stock over the past week After last week's 45% share price gain to zł1.41, the stock is trading at a trailing P/E ratio of 62.2x, up from the previous P/E ratio of 42.8x. This compares to an average P/E of 12x in the Capital Markets industry in Poland. Total returns to shareholders over the past three years are 182%. Valuation Update With 7 Day Price Move • Oct 26
Market pulls back on stock over the past week After last week's 33% share price decline to zł1.10, the stock is trading at a trailing P/E ratio of 48.5x, down from the previous P/E ratio of 72.8x. This compares to an average P/E of 13x in the Capital Markets industry in Poland. Total returns to shareholders over the past three years are 112%. Valuation Update With 7 Day Price Move • Oct 19
Market bids up stock over the past week After last week's 79% share price gain to zł1.65, the stock is trading at a trailing P/E ratio of 72.8x, up from the previous P/E ratio of 40.6x. This compares to an average P/E of 12x in the Capital Markets industry in Poland. Total returns to shareholders over the past three years are 206%. Reported Earnings • Oct 15
Third quarter earnings released Over the last 12 months the company has reported total profits of zł84.8k, down 53% from the prior year. Total revenue was zł7.29m over the last 12 months, up 5.8% from the prior year. Is New 90 Day High Low • Oct 12
New 90-day high: zł0.92 The company is up 109% from its price of zł0.44 on 14 July 2020. The Polish market is down 4.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Capital Markets industry, which is up 6.0% over the same period.